Genexine, Inc. (095700.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 2,920.00

From 52W high−60.07%

Volume291483.00

Market capKRW 128.90B

P/E (TTM)—

P/S (TTM)25.9x

Div yield—

Key dataSep 18, 2026

Open

KRW 2,920.00

From 52W high

−60.07%

Volume

291483.00

Market cap

KRW 128.90B

ValuationView details →

P/E (Fwd)

4.5x

EV/EBITDA

467.8x

P/E (TTM)

—

RSI (14)

52.3

MomentumView details →

1D Return

+1.43%

YTD Return

−38.10%

ValuationView details →

P/E (Fwd)

4.5x

P/E (TTM)

—

EV/EBITDA

467.8x

EV/Sales

43.9x

P/S (TTM)

25.9x

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

−62.74%

Net Margin

−645.91%

EBITDA Margin

9.38%

ROE (TTM)

−16.04%

ROA (TTM)

−9.68%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

+229.89%

EPS YoY

+57.99%

FCF YoY

−70.83%

Revenue CAGR 3Y

−34.31%

EPS CAGR 3Y

+60.68%

EBITDA YoY

+101.08%

MomentumView details →

1D Return

+1.43%

YTD Return

−38.10%

1Y Return

−46.98%

RSI (14)

52.3

vs 50D SMA

+8.57%

vs 200D SMA

−27.91%

Capital & dividendView details →

Debt/Equity

0.57x

Current Ratio

0.27x

Quick Ratio

0.27x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−KRW 577.57

EPS Surprise

−465.99%

Beats (12Q)

0/12

Next Q EPS Est

KRW 157.81

Avg Surprise (4Q)

−465.99%

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

4.97B

Net Income (TTM)

−32.10B

Op. CF (TTM)

−28.13B

Latest newsMore news →

No recent news for 095700.KQ.

Similar companies

Vertex Pharmaceuticals IncorporatedVRTX Macrogen, Inc.038290.KQ Helixmith Co., Ltd084990.KQ Anterogen.Co.,Ltd.065660.KQ ORIENT BIO Inc.002630.KS Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK Find similar companies →

Latest newsMore news →

No recent news for 095700.KQ.